Endophthalmitis in Eyes With the Boston Type I Keratoprosthesis: Incidence, Recurrence, Risk Factors, and Outcomes

Cristina Bostan1, Taylor Nayman1, Andrei-Alexandru Szigiato1

  • 1Department of Ophthalmology, Centre hospitalier de l'Université de Montréal, Montreal, Canada; and.

Cornea
|January 4, 2021
PubMed
Abstract

Insights

Boston type I keratoprosthesis (KPro) endophthalmitis is rare but can threaten vision and the globe. Prompt treatment of corneal melts and infectious keratitis, careful consideration of postoperative contact lenses, and enhanced prophylaxis for ocular burn patients are crucial.

Area of Science:

  • Ophthalmology
  • Cornea
  • Prosthetic Surgery

Background:

  • Boston type I keratoprosthesis (KPro) is a vital solution for end-stage corneal diseases.
  • Endophthalmitis is a serious complication following intraocular surgery, including KPro implantation.
  • Understanding KPro-associated endophthalmitis is crucial for optimizing patient outcomes.

Purpose of the Study:

  • To investigate the incidence, recurrence, and microbiological characteristics of Boston type I KPro-associated endophthalmitis.
  • To identify risk factors associated with the development of KPro endophthalmitis.
  • To evaluate the outcomes of KPro endophthalmitis, including visual acuity, prosthesis retention, and globe salvage.

Main Methods:

  • Retrospective analysis of 158 consecutive Boston type I KPro procedures.
  • Review of medical charts for ocular history, prior treatments, and postoperative complications.
  • Cox regression analysis to identify risk factors and compare outcomes between eyes with and without endophthalmitis.

Main Results:

  • The incidence and recurrence rates of endophthalmitis were 1.7% and 6.0% per procedure-year, respectively.
  • Key risk factors included previous ocular burns, infectious keratitis, corneal melt, and postoperative contact lens wear.
  • Eyes with endophthalmitis had increased risk of KPro explantation and evisceration, with all eyes experiencing significant vision loss.

Conclusions:

  • Endophthalmitis following Boston type I KPro implantation is uncommon but carries significant risks to vision and globe integrity.
  • Prompt management of corneal melt and infectious keratitis is essential.
  • Individualized decisions regarding postoperative contact lens use and potentially more aggressive antimicrobial prophylaxis for high-risk patients (e.g., ocular burns) are recommended.

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
832
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
958